3 results about "Pain heart" patented technology

The invention discloses milk-nourishing rhodiola rosea as well as a processing technology and application thereof, and belongs to the technical field of traditional Chinese medicine processing. The processing technology comprises the following steps: taking a proper amount of a pretreated rhodiola rosea medicinal material, coarsely crushing, adding milk which is 3 times of the weight of the rhodiola rosea medicinal material, moistening, boiling with slow fire until the milk is completely absorbed, and drying. According to the milk nourishing rhodiola rosea, the salidroside content is not less than 0.50%, the extract content is not less than 25%, the acid-insoluble ash content is not less than 2.0%, the total ash content is not less than 8.0%, and the water content is not less than 12%. The invention relates to application of milk-nourishing rhodiola rosea in preparation of medicines for treating qi deficiency and blood stasis, chest stuffiness and pains, apoplexy hemiplegia and tiredness and asthma. According to the milk processed rhodiola rosea, the effect of the rhodiola rosea is improved, the bitter taste of the rhodiola rosea is effectively neutralized, the taste is softer, and the milk processed rhodiola rosea has a good development prospect.

This invention relates to the field of traditional Chinese medicine preparation technology, specifically to a Qi-invigorating and blood-activating granule for heart pain and its preparation method, comprising the following raw materials in parts by weight: 25-35 parts of raw Astragalus membranaceus, 10-20 parts of Angelica sinensis, 5-15 parts of ginseng, 4-8 parts of Panax notoginseng, 10-20 parts of Ligusticum chuanxiong, 8-12 parts of earthworm, and 2-4 parts of leech. This invention precisely targets the core pathogenesis of Qi deficiency and blood stasis syndrome, which is "Qi deficiency as the root and blood stasis as the manifestation," selecting raw Astragalus membranaceus and ginseng as the core Qi-invigorating components, and Panax notoginseng, leech, Ligusticum chuanxiong, Angelica sinensis, and earthworm as the core blood-activating components. The formulation follows the traditional Chinese medicine principle of "invigorating Qi to promote blood circulation without harming the body's vital energy." The dosage of each raw material has been optimized through systematic experiments to form a specific range of parts by weight, solving the technical problems of poor targeting and insufficient synergy in existing formulations.

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating thoracic obstruction phlegm-qi stagnation type cardiovascular diseases and a preparation method and application thereof. The traditional Chinese medicine composition is prepared from fructus trichosanthis, rhizoma pinelliae preparata, arisaema cum bile, fructus aurantii, cortex magnoliae officinalis, pericarpium citri reticulatae, poria cocos and honey-fried licorice root. The traditional Chinese medicine composition disclosed by the invention has the effects of tonifying qi and relieving chest stuffiness and arthralgia, is mainly used for treating chest stuffiness and pains and phlegm-qi stagnation type cardiovascular diseases, and is particularly suitable for patients suffering from coronary heart disease and angina pectoris. Besides, on the basis of a traditional medical formula, a modern preparation process is utilized and deeply optimized, and a dynamic decoction process and a one-step granulation technology are adopted, so that the preparation method has the advantages of simple and convenient preparation process, high efficiency, energy conservation, less damage to effective components and the like.